So far, the proposed treatment of NAFL in PCOS includes life style changes, GLP1 receptor agonists, spironolactone, thiazolidinedione (in non-obese people with PCOS), metformin, and nutritional supplements containing 1000 mg omega-3 fatty acids (containing 400 mg of α-linolenic acid) and 400 IU vitamin E [43]. Here, GLP1R is linked to non-alcoholic fatty liver.